HARMONY will be attending the 46th European Society for Blood and Marrow Transplantation (EBMT) meeting in Madrid. This year's meeting will be virtual and will take place from August 29–September 1, 2020. The EBMT is a highly valued HARMONY Partner.
The HARMONY Alliance is a European public–private partnership that is capturing and mining Big Data on seven different hematologic malignancies with the aim of accelerating the development of more effective treatments. The information is stored in HARMONY’s Big Data Platform, which now contains more than 50,000 anonymized patient records, making it one of the largest databases of its kind. Leading research teams are currently using this wealth of information to answer critical questions about hematologic malignancies that cannot be addressed with other methods.
Step 1 enter the virtual exhbition | Step 2 click on 'Exhibition Halls' | Step 3 click on Hall 4 and locate our booth on the top
The annual EBMT meeting connects scientific and clinical professionals across the globe working in the field of clinical bone marrow transplantation and cellular therapy, enabling the exchange of expertise in these therapy areas. Click here to visit the official EBMT congress website and view the scientific agenda.
EBMT is a HARMONY Partner. Watch Anna Sureda, Scientific Chair of the EBMT, speak about the exciting sessions on chimeric antigen-receptor (CAR) T-cells that will taking place during the 2020 EBMT meeting:
See what other meetings HARMONY is holding and attending by visiting our meetings page.
Become involved with HARMONY today! Contact us to find out how you can participate in ongoing and future research initiatives.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
